Preliminary results: Outcome of liver transplantation for hepatitis B virus varies by hepatitis B virus genotype

Harshad C. Devarbhavi, Ari J. Cohen, Robin Patel, Russell H. Wiesner, Rolland Dickson, Michael B. Ishitani

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Hepatitis B virus (HBV) is a leading cause of liver failure throughout the world. HBV has seven different genotypes based on variations within the viral nucleotide sequence. Initially, patients who underwent liver transplantation for HBV had high recurrence rates and poor survival. Recently, improved outcomes have been reported when patients are administered hepatitis B immunoglobulin (HBIg) infusions to maintain high serum hepatitis B surface antibody titers after transplantation. Unfortunately, recurrence rates are still high in patients with active pretransplant HBV replication. The aims of this study are to evaluate the impact of HBV genotype on pretransplantation HBV replication and posttransplantation HBV recurrence rate, morbidity, and mortality. Sera from 22 patients who underwent transplantation for HBV at our center were tested for HBV genotype by an enzyme-linked immunosorbent assay technique using monoclonal antibodies to the pre-S2 region. All patients were administered HBIg after transplantation; 5 patients were administered both lamivudine and HBIg. HBV genotypes were distributed as follows: genotype A (10 patients), genotype C (6 patients), genotype D (5 patients), and genotype E (1 patient). Pretransplantation HBV replication was most common with genotype A (80%), whereas less so with genotypes C (33%) and D (40%). Nine patients (41%) developed recurrent HBV infection: genotype A (2 patients; 20%), genotype C (3 patients; 50%), and genotype D (4 patients; 80%). Mortality was greatest with genotype D (40%). Our data suggest that patients with genotype A have the lowest risk for HBV recurrence despite having the highest rate of pretransplantation HBV viral replication. Patients with genotype D appear to have the highest risk for HBV recurrence and mortality. Additional larger multicenter studies are needed to confirm these findings.

Original languageEnglish (US)
Pages (from-to)550-555
Number of pages6
JournalLiver Transplantation
Volume8
Issue number6
DOIs
StatePublished - 2002

Fingerprint

Hepatitis B virus
Liver Transplantation
Genotype
Virus Replication
Recurrence
Hepatitis B
Immunoglobulins
Transplantation
Mortality
Immunosorbent Techniques
Hepatitis B Antibodies
Lamivudine
Liver Failure
Virus Diseases
Serum
Multicenter Studies
Survival Rate

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Preliminary results : Outcome of liver transplantation for hepatitis B virus varies by hepatitis B virus genotype. / Devarbhavi, Harshad C.; Cohen, Ari J.; Patel, Robin; Wiesner, Russell H.; Dickson, Rolland; Ishitani, Michael B.

In: Liver Transplantation, Vol. 8, No. 6, 2002, p. 550-555.

Research output: Contribution to journalArticle

Devarbhavi, Harshad C. ; Cohen, Ari J. ; Patel, Robin ; Wiesner, Russell H. ; Dickson, Rolland ; Ishitani, Michael B. / Preliminary results : Outcome of liver transplantation for hepatitis B virus varies by hepatitis B virus genotype. In: Liver Transplantation. 2002 ; Vol. 8, No. 6. pp. 550-555.
@article{813ab76e51d64210a8833e168b6e3d4f,
title = "Preliminary results: Outcome of liver transplantation for hepatitis B virus varies by hepatitis B virus genotype",
abstract = "Hepatitis B virus (HBV) is a leading cause of liver failure throughout the world. HBV has seven different genotypes based on variations within the viral nucleotide sequence. Initially, patients who underwent liver transplantation for HBV had high recurrence rates and poor survival. Recently, improved outcomes have been reported when patients are administered hepatitis B immunoglobulin (HBIg) infusions to maintain high serum hepatitis B surface antibody titers after transplantation. Unfortunately, recurrence rates are still high in patients with active pretransplant HBV replication. The aims of this study are to evaluate the impact of HBV genotype on pretransplantation HBV replication and posttransplantation HBV recurrence rate, morbidity, and mortality. Sera from 22 patients who underwent transplantation for HBV at our center were tested for HBV genotype by an enzyme-linked immunosorbent assay technique using monoclonal antibodies to the pre-S2 region. All patients were administered HBIg after transplantation; 5 patients were administered both lamivudine and HBIg. HBV genotypes were distributed as follows: genotype A (10 patients), genotype C (6 patients), genotype D (5 patients), and genotype E (1 patient). Pretransplantation HBV replication was most common with genotype A (80{\%}), whereas less so with genotypes C (33{\%}) and D (40{\%}). Nine patients (41{\%}) developed recurrent HBV infection: genotype A (2 patients; 20{\%}), genotype C (3 patients; 50{\%}), and genotype D (4 patients; 80{\%}). Mortality was greatest with genotype D (40{\%}). Our data suggest that patients with genotype A have the lowest risk for HBV recurrence despite having the highest rate of pretransplantation HBV viral replication. Patients with genotype D appear to have the highest risk for HBV recurrence and mortality. Additional larger multicenter studies are needed to confirm these findings.",
author = "Devarbhavi, {Harshad C.} and Cohen, {Ari J.} and Robin Patel and Wiesner, {Russell H.} and Rolland Dickson and Ishitani, {Michael B.}",
year = "2002",
doi = "10.1053/jlts.2002.33483",
language = "English (US)",
volume = "8",
pages = "550--555",
journal = "Liver Transplantation",
issn = "1527-6465",
publisher = "John Wiley and Sons Ltd",
number = "6",

}

TY - JOUR

T1 - Preliminary results

T2 - Outcome of liver transplantation for hepatitis B virus varies by hepatitis B virus genotype

AU - Devarbhavi, Harshad C.

AU - Cohen, Ari J.

AU - Patel, Robin

AU - Wiesner, Russell H.

AU - Dickson, Rolland

AU - Ishitani, Michael B.

PY - 2002

Y1 - 2002

N2 - Hepatitis B virus (HBV) is a leading cause of liver failure throughout the world. HBV has seven different genotypes based on variations within the viral nucleotide sequence. Initially, patients who underwent liver transplantation for HBV had high recurrence rates and poor survival. Recently, improved outcomes have been reported when patients are administered hepatitis B immunoglobulin (HBIg) infusions to maintain high serum hepatitis B surface antibody titers after transplantation. Unfortunately, recurrence rates are still high in patients with active pretransplant HBV replication. The aims of this study are to evaluate the impact of HBV genotype on pretransplantation HBV replication and posttransplantation HBV recurrence rate, morbidity, and mortality. Sera from 22 patients who underwent transplantation for HBV at our center were tested for HBV genotype by an enzyme-linked immunosorbent assay technique using monoclonal antibodies to the pre-S2 region. All patients were administered HBIg after transplantation; 5 patients were administered both lamivudine and HBIg. HBV genotypes were distributed as follows: genotype A (10 patients), genotype C (6 patients), genotype D (5 patients), and genotype E (1 patient). Pretransplantation HBV replication was most common with genotype A (80%), whereas less so with genotypes C (33%) and D (40%). Nine patients (41%) developed recurrent HBV infection: genotype A (2 patients; 20%), genotype C (3 patients; 50%), and genotype D (4 patients; 80%). Mortality was greatest with genotype D (40%). Our data suggest that patients with genotype A have the lowest risk for HBV recurrence despite having the highest rate of pretransplantation HBV viral replication. Patients with genotype D appear to have the highest risk for HBV recurrence and mortality. Additional larger multicenter studies are needed to confirm these findings.

AB - Hepatitis B virus (HBV) is a leading cause of liver failure throughout the world. HBV has seven different genotypes based on variations within the viral nucleotide sequence. Initially, patients who underwent liver transplantation for HBV had high recurrence rates and poor survival. Recently, improved outcomes have been reported when patients are administered hepatitis B immunoglobulin (HBIg) infusions to maintain high serum hepatitis B surface antibody titers after transplantation. Unfortunately, recurrence rates are still high in patients with active pretransplant HBV replication. The aims of this study are to evaluate the impact of HBV genotype on pretransplantation HBV replication and posttransplantation HBV recurrence rate, morbidity, and mortality. Sera from 22 patients who underwent transplantation for HBV at our center were tested for HBV genotype by an enzyme-linked immunosorbent assay technique using monoclonal antibodies to the pre-S2 region. All patients were administered HBIg after transplantation; 5 patients were administered both lamivudine and HBIg. HBV genotypes were distributed as follows: genotype A (10 patients), genotype C (6 patients), genotype D (5 patients), and genotype E (1 patient). Pretransplantation HBV replication was most common with genotype A (80%), whereas less so with genotypes C (33%) and D (40%). Nine patients (41%) developed recurrent HBV infection: genotype A (2 patients; 20%), genotype C (3 patients; 50%), and genotype D (4 patients; 80%). Mortality was greatest with genotype D (40%). Our data suggest that patients with genotype A have the lowest risk for HBV recurrence despite having the highest rate of pretransplantation HBV viral replication. Patients with genotype D appear to have the highest risk for HBV recurrence and mortality. Additional larger multicenter studies are needed to confirm these findings.

UR - http://www.scopus.com/inward/record.url?scp=0036270569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036270569&partnerID=8YFLogxK

U2 - 10.1053/jlts.2002.33483

DO - 10.1053/jlts.2002.33483

M3 - Article

C2 - 12037787

AN - SCOPUS:0036270569

VL - 8

SP - 550

EP - 555

JO - Liver Transplantation

JF - Liver Transplantation

SN - 1527-6465

IS - 6

ER -